P H Jiang1, F Chany-Fournier, J Galabru
1Institut National de la Santé de la Recherche Médicale, Unité 43, Hôpital Saint Vincent de Paul.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Sarcolectins, interferon antagonists, reduce antiviral protection by decreasing key enzymes like 2-5A synthetase and protein kinase. These sarcolectins may counteract interferon
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: